Monthly Archives: November 2024

20 parliamentarians have signed a letter to the Secretary of State for Health and Social Care, Wes Streeting MP, calling for urgent government action to safeguard the future of community pharmacies. Supported by Community Pharmacy England, the cross-party letter describes the financial challenges facing the sector and calls on the Department of Health and Social [...]

The post Parliamentarians urge Government action to support community pharmacies in letter to Health Secretary appeared first on Community Pharmacy England.

The deadline to register interest in participating in an important fiscal review of the community pharmacy sector has been extended to Monday 18th November. With pharmacies across the country struggling to cope under intolerable financial pressures, NHS England’s independent economic review offers an opportunity to demonstrate how much it actually costs to run a pharmacy [...]

The post DEADLINE EXTENDED: Help inform review of sector costs appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) Drug alert number: EL (24)A/54 Date issued: 12 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole 40mg Powder for solution for infusion. Company name: Viatris [...]

The post MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium fusidate (Fucidin®) 250mg tablets and fusidic acid (Fucidin®) 250mg/5ml oral suspension MSN/2024/107 Tier 2 medium impact Date of issue: 7th October 2024 Sodium fusidate (Fucidin®) 250mg tablets will be discontinued from mid-January 2025. Fusidic acid (Fucidin®) 250mg/5ml oral suspension will [...]

The post Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension appeared first on Community Pharmacy England.

LPCs and Community Pharmacy England met with a range of advocates and patient groups last week to reflect on the outlook for the sector a year on from the publication of the Vision for Community Pharmacy. The Annual Conference of LPCs and Community Pharmacy England held last Thursday focussed on crucial considerations for the coming year, [...]

The post One Year on from Vision: LPCs and wider stakeholders consider the outlook for pharmacy appeared first on Community Pharmacy England.